Regulus Therapeutics Inc (DELISTED) (RGLS:DL)
8.16
0.00 (0.00%)
USD |
NASDAQ |
Jun 30, 16:00
Regulus Therapeutics Shareholders Equity (Quarterly): 69.03M for March 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 6.741B |
| SpringWorks Therapeutics Inc (DELISTED) | 417.40M |
| CorMedix, Inc. | 374.13M |
| BioCardia, Inc. | 2.627M |
| Xeris Biopharma Holdings, Inc. | -0.861M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 74.83M |
| Total Liabilities (Quarterly) | 5.798M |